Cardiovascular Business - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
Cardiovascular Business

Cardiovascular Business

Publication
0 followers

Cardiology operations, devices and technology in care delivery

Recent Posts

Gore Completes Acquisition of Conformal Medical
Deals•Feb 19, 2026

Gore Completes Acquisition of Conformal Medical

W. L. Gore & Associates, the materials‑science company, has finalized its acquisition of Conformal Medical, the developer of the CLAAS AcuFORM left atrial appendage occlusion system. Financial terms were not disclosed. Conformal Medical becomes a wholly‑owned subsidiary of Gore, continuing development of its heart‑device platform.

Cardiovascular Business
AI-Powered MRI Evaluations Predict STEMI Outcomes Better than Existing Risk Scores
News•Feb 17, 2026

AI-Powered MRI Evaluations Predict STEMI Outcomes Better than Existing Risk Scores

A machine‑learning model that combines cardiac MRI data with clinical variables predicts long‑term major adverse cardiovascular events (MACE) in STEMI patients more accurately than the GRACE and TIMI scores. The study analyzed 1,066 patients, training on 682 cases and testing...

By Cardiovascular Business
TAVR Linked to Higher Reintervention Rate than SAVR in Evolut Low Risk Trial Update
News•Feb 17, 2026

TAVR Linked to Higher Reintervention Rate than SAVR in Evolut Low Risk Trial Update

A six‑year update of the Medtronic‑funded Evolut Low Risk trial shows that transcatheter aortic valve replacement (TAVR) with a self‑expanding valve has a higher reintervention rate than surgical aortic valve replacement (SAVR) in low‑risk patients—5.5% versus 3.3% at six years,...

By Cardiovascular Business
FDA Clears 12-Lead, Cable-Free Home ECG Monitoring System
News•Feb 17, 2026

FDA Clears 12-Lead, Cable-Free Home ECG Monitoring System

The FDA granted 510(k) clearance for HeartBeam’s cable‑free 12‑lead ECG synthesis software, allowing home‑based arrhythmia assessment. The system captures cardiac signals in three non‑coplanar dimensions and reconstructs a full 12‑lead trace that can be reviewed by board‑certified cardiologists on demand....

By Cardiovascular Business
CVRx Highlights Revenue Growth in Q4, Increased Momentum Going Forward
News•Feb 13, 2026

CVRx Highlights Revenue Growth in Q4, Increased Momentum Going Forward

CVRx reported fourth‑quarter 2025 revenue of $16 million, a 4% year‑over‑year increase. Full‑year revenue rose 10% to $56.7 million, and the network of active implanting centers expanded to 252. The company secured Category 1 CPT codes for its Barostim device effective Jan 1 2026 and...

By Cardiovascular Business
CCTA Becoming an Essential Tool for Interventional Cardiologists
News•Feb 13, 2026

CCTA Becoming an Essential Tool for Interventional Cardiologists

Coronary computed tomography angiography (CCTA) is becoming a core tool for interventional cardiologists, enabling comprehensive pre‑procedure planning and reducing reliance on costly intravascular imaging. The addition of fractional flow reserve derived from CT (FFR‑CT) merges anatomical and physiological assessment, streamlining...

By Cardiovascular Business

Page 2 of 2

← Prev12